Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00632281 · ClinicalTrials.gov registry record · NA

Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT00632281 is a NA study that has completed, run by University of Florida. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00632281, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

The purpose of this research study is to determine if Stereotactic Body Radiation Therapy(SBRT) is a good way to treat tumors near the thorax. Stereotactic Body Radiation Therapy (SBRT) is a general term for a group of techniques that are designed to deliver radiation therapy in a way that damages normal tissues less than conventional radiotherapy. The two features that distinguish SBRT from conventional therapy are procedures that decrease errors in patient positioning and technology that results in a radiation dose distribution that conforms more tightly to the tumor target. Patients will receive either 48 Gy or 60 Gy fractions depending on the type of tumor. The majority of patients will be treated in 1 week, Monday through Friday, with Wednesday off.

Interventions

  • RADIATION Stereotactic Body Radiation Therapy

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2006-01
Est. Completion 2008-11
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT00632281

The ClinicalTrials.gov registry entry for NCT00632281 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Stereotactic Body Radiation Therapy is the first listed.

NCT00632281 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00632281 about?

NCT00632281 is a clinical study titled "Stereotactic Body Radiation Therapy (SBRT) for Lung Tumors". The purpose of this research study is to determine if Stereotactic Body Radiation Therapy(SBRT) is a good way to treat tumors near the thorax. Stereotactic Body Radiation Therapy (SBRT) is a general term for a group of techniques that are designed to deliver radiation therapy in a way that damages n...

What is the current status of trial NCT00632281?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2006-01. Estimated completion is 2008-11.

What interventions are being tested in trial NCT00632281?

The interventions under investigation include: Stereotactic Body Radiation Therapy (RADIATION).

Who is sponsoring clinical trial NCT00632281?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.